Multipotent Stem Cells are a type of adult or somatic stem cell with the ability to differentiate into a limited range of cell types within a specific tissue or organ. Unlike pluripotent stem cells, which can differentiate into cells of any embryonic germ layer, multipotent stem cells are more specialized and have a more restricted differentiation potential. Multipotent stem cells are found in various tissues throughout the body, including the bone marrow, adipose tissue, and the umbilical cord. The differentiation potential of multipotent stem cells is crucial for tissue homeostasis, repair, and regeneration. These cells contribute to the replenishment of specific cell types lost due to normal turnover, injury, or disease. While not as versatile as pluripotent stem cells, multipotent stem cells are valuable in regenerative medicine and tissue engineering. They have been explored for their therapeutic potential in treating various conditions, including cardiovascular diseases, orthopedic injuries, and neurodegenerative disorders. Understanding the molecular mechanisms that regulate the differentiation of multipotent stem cells is essential for harnessing their regenerative capabilities. Ongoing research aims to elucidate these mechanisms and develop strategies to manipulate and utilize multipotent stem cells for therapeutic purposes.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy